Drawing for BONE MATTERS

USPTO serial 87500087

BONE MATTERS

Reviewed by CopyMark Law Group

Reg. 5840205Status 702Registered
Filing date
Status date
Registration date
Aug 20, 2019
Examiner
MUNN LEWIS, LAKEISHA S
Law office
POST REGISTRATION

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with BONE MATTERS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elsa D. Lemoine

Elsa D. Lemoine Amgen Inc.One Amgen Center DriveTrademark Operations - MS-28-5AThousand Oaks, CA 91320-1799

Goods and services

ClassDescriptionStatusFirst use
041Providing online publications in the nature of brochures and newsletters in the fields of pharmaceuticals, medicines, bone disorders, and health; [ arranging and conducting classes, seminars and workshops in the fields of pharmaceuticals, medicines, bone disorders and health; ] educational services, namely, programs about pharmaceuticals, medicines, bone disorders and health accessible by means of [ audio, video, ] web-based applications, mobile phone applications, and computer networks; educational services, namely, conducting programs in the fields of pharmaceuticals, medicines, bone disorders and healthACTIVEMay 6, 2019
042Research and development of pharmaceutical preparations and medicines; providing websites featuring medical and scientific research information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals preparations and medicines; providing websites featuring medical and scientific research information about pharmaceuticals preparations and medicines; providing online non-downloadable computer software used to access, manage, update and display electronic databases in the fields of pharmaceutical preparations and medicinesACTIVEMay 6, 2019
044Support services in the nature of a helpdesk, namely, providing medical and health information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals preparations and medicinesACTIVEMay 6, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 3, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Feb 3, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 26, 2026EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jan 26, 2026PUMIPROOF OF USE INTERIM ACTION ISSUED—
Jan 21, 2026EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Aug 24, 2025PUM1OFFICE ACTION ISSUED POU1—
Aug 24, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 4, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Feb 25, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 25, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 25, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 25, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 25, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 20, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 29, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 29, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 29, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 29, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 29, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 29, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 20, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 19, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 18, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 13, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 12, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 31, 2019IUAFUSE AMENDMENT FILED—
May 31, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 7, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 7, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 11, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 9, 2019EX1GSOU EXTENSION 1 GRANTED—
Jan 9, 2019EXT1SOU EXTENSION 1 FILED—
Jan 9, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 17, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 22, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 22, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 2, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 16, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 21, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 21, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 21, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2017CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Sep 27, 2017ALIEASSIGNED TO LIE—
Sep 27, 2017GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Sep 27, 2017GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Sep 27, 2017CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Sep 19, 2017DOCKASSIGNED TO EXAMINER—
Jun 28, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 24, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance